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A Systematic Review and Meta-analysis on Omentoplasty for the
Management of Abdominoperineal Defects in
Patients Treated for Cancer
Robin D. Blok, MD,y Jan A. W. Hagemans, MD,z Charlotte E. L. Klaver, MD, Joke Hellinga, MD,§
Boudewijn van Etten, MD, PhD, Jacobus W. A. Burger, MD, PhD,zjj Cornelis Verhoef, MD, PhD,z
Roel Hompes, MD, Wilhelmus A. Bemelman, MD, PhD, and Pieter J. Tanis, MD, PhD
Objective: The objective of this systematic review and meta-analysis was to
examine the effects of omentoplasty on pelviperineal morbidity following
abdominoperineal resection (APR) in patients with cancer.
Background: Recent studies have questioned the use of omentoplasty for the
prevention of perineal wound complications.
Methods: A systematic review of published literature since 2000 on the use
of omentoplasty during APR for cancer was undertaken. The authors were
requested to share their source patient data. Meta-analyses were conducted
using a random-effects model.
Results: Fourteen studies comprising 1894 patients (n ¼ 839 omentoplasty)
were included. The majority had APR for rectal cancer (87%). Omentoplasty
was not significantly associated with the risk of presacral abscess formation in
the overall population (RR 1.11; 95% CI 0.79–1.56), nor in planned subgroup
analysis (n ¼ 758) of APR with primary perineal closure for nonlocally
advanced rectal cancer (RR 1.06; 95% CI 0.68–1.64). No overall differences
were found for complicated perineal wound healing within 30 days (RR 1.30;
95%CI 0.92–1.82), chronic perineal sinus (RR 1.08; 95%CI 0.53–2.20), and
pelviperineal complication necessitating reoperation (RR 1.06; 95% CI 0.80–
1.42) as well. An increased risk of developing a perineal hernia was found for
patients submitted to omentoplasty (RR 1.85; 95% CI 1.26–2.72). Compli-
cations related to the omentoplasty were reported in 4.6% (95% CI 2.5%–
8.6%).
Conclusions: This meta-analysis revealed no beneficial effect of omento-
plasty on presacral abscess formation and perineal wound healing after APR,
while it increases the likelihood of developing a perineal hernia. These
findings do not support the routine use of omentoplasty in APR for cancer.
Keywords: abdominoperineal resection, omentoplasty, perineal hernia,
perineal wound healing, presacral abscess, surgical oncology
(Ann Surg 2020;271:654–662)
T he pelvic wound bed after abdominoperineal resection (APR)carries a high risk of morbidity.1–3 This is likely related to the
contaminated operative field and dead space formation with fluid
accumulation, and may be further increased by extended resections
and compromised perfusion postradiotherapy. A randomized con-
trolled trial showed that perineal complications within 1 year after
APRwith primary perineal closure may occur in up to 48%.4 Patients
frequently develop perineal wound dehiscence and infection, and
often endure delayed healing. Secondary wound healing can take
several months andmay eventually result in a chronic perineal sinus.5
Furthermore, patients may develop perineal pain and sitting prob-
lems, as well as a perineal hernia.6,7
To improve perineal wound healing after APR, various recon-
structive methods have been proposed. These include the use of a
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biological mesh and several tissue flaps, such as a pedicled omento-
plasty (OP) or a vertical rectus abdominis muscle flap (VRAM).8–10
The flaps serve to obliterate the often noncollapsible defect with
healthy and well perfused tissue, which has been associated with
reduced abscess formation and improved wound healing.11,12
The omentum is supposedly an ideal option to prevent dead
space formation after APR. It has a rich blood supply, expresses anti-
inflammatory cytokines, often provides for abundant bulk, and
appears relatively easy to release.13–16 Many surgeons therefore
perform an OP as part of the APR procedure. In a recent nationwide
study with variability in practice of applying OP, no improvement in
perineal wound healing was observed, and the OP particularly
seemed to increase the risk of perineal herniation.6 These results
challenge the value of OP for closure of the pelvic defect after APR.
Therefore, the aim of this systematic review andmeta-analysis was to
assess the effects of OP following APR on pelviperineal morbidity
and related problems in patients treated for cancer in the published
literature since 2000.
METHODS
The study protocol was prospectively registered at PROS-
PERO (registration number: CRD42017073573) and followed Pre-
ferred Reporting Items for Systematic Reviews and Meta-analysis
(PRISMA) guidance.17
Search
The literature was systematically reviewed by searching in the
PubMed-library for studies published between January 2000 and
March 2017. The search was limited to publication since 2000 to
limit the influence of historical changes in surgical and perioperative
care, which better ties in to current practices. The search was rerun in
June 2018 (Supplementary Digital Content 1, http://links.lww.com/
SLA/B624). The search strategy only included terms relating to or
describing neoplasms, surgical outcome, and APR. Since most
studies do not explicitly mention the use of OP in the title or abstract,
this was not included as a search term. Additional articles were
manually selected from the reference lists of the retrieved papers.
Eligibility
Original studies including patients undergoing APR for cancer
and reporting on use of OP and perineal wound outcome were
potentially eligible. Articles were restricted to the English language.
Exclusion criteria were studies with no original data, individual case
reports (<10 patients with OP), studies that did not report on at least
1 predefined outcome of interest, and studies that exclusively per-
tained to pelvic exenteration or benign disease.
Outcome Parameters
The primary endpoint was incidence of presacral abscess
formation, as this was expected to be most consistently reported.
Secondary endpoints were the rate of overall pelviperineal wound
complications within 30 days, 1 year, and the total study period,
wound healing time, specific pelviperineal morbidity (ie, wound
dehiscence, superficial wound infection, hemorrhage, perineal
sinus), ileus (overall, and proportion requiring reoperation), perineal
hernia (not specified), OP-related morbidity, operative time, and
surgical perineal reintervention. Pelviperineal complication included
any pelvic or perineal wound event (including perineal hernia), and
surgical perineal reintervention any pelvic or perineal wound-related
reoperation (including hernia repair). Perineal infection was catego-
rized into superficial wound infection (including perineal abscess),
and deep wound infection (ie, presacral abscess). Perineal hemor-
rhage included active perineal bleeding or hematoma (regardless of
need for reintervention). There was no definition given for presacral
abscess, perineal sinus, and perineal hernia. Perineal hernia was
based on the reporting of the source studies, and could vary from
asymptomatic incidental computed tomography finding to symptom-
atic perineal bulge requiring surgical repair.
Data Collection and Extraction
Two independent reviewers (R.D.B. and C.E.L.K.) scanned all
abstracts identified by the search and cross-referencing. Full texts
were retrieved for all studies that potentially met the inclusion
criteria. Two reviewers (R.D.B. and J.A.W.H.) further independently
reviewed the eligibility of these studies in full text. Any disagreement
on the eligibility of particular studies was resolved through consen-
sus discussion with a third reviewer (P.J.T.). Papers not meeting the
inclusion criteria were excluded and listed with reason for omission
(Fig. 1). All authors were contacted on 3 separate occasions to share
either the source individual patient data or aggregate data, reported
separately for OP and non-OP.
Data extraction included general study information, partici-
pant demographics, operative details, perineal wound outcome,
length of follow-up, and information for assessment of the risk of
bias. Any disagreement was solved by consensus discussion, if
necessary with a third reviewer (P.J.T.). In case of missing data,
the study authors were contacted to request additional information.
The received source patient data was preferably used, and may
slightly differ from the original publication. If this was not available,
data from the original publication was used. The cohort of Musters
et al5 was updated using original patient files. From the initial 104
patients of the BIOPEX study, 99 were entered in the analyses
because of missing outcome data due to study exclusions.4
Assessment of Risk of Bias in Included Studies
Two reviewers (R.D.B. and J.A.W.H.) independently assessed
the risk of bias in the included studies using the Newcastle-Ottawa
Scale for nonrandomized studies.18,19
Data Synthesis
All outcome measures were quantitatively summarized. If at
least 3 comparative studies (10 cases in both groups) provided data
on a study parameter, data were pooled in meta-analysis using
Review Manager (RevMan 5; Cochrane Collaboration). Studies
without a control (<10 cases of non-OP) were pooled in proportional
meta-analysis using RStudio (version 3.5.1). Pooled estimates of
effect were calculated along with corresponding 95% confidence
interval (CI), using a random-effects model. The method as proposed
by Wan et al20 was used to approximate the estimation of the sample
mean and standard deviation in case the median and interquartile
range was given. Dichotomous data were summarized by risk ratios
(RR), and continuous data were presented as mean differences.
Heterogeneity between studies was perceived considerable when
I275%.21 Two-sided P values <0.05 were considered statistically
significant. Funnel plots were generated to assess for publication
bias. The evidence along with the quality of the data was summarized
in a GRADE summary of findings table.
Analysis of Subgroups
To decrease potential bias introduced by diverse indication
and surgical methods, a planned subgroup analysis was performed
for patients who underwent APR with primary perineal closure for
nonlocally advanced rectal cancer. The additional exclusion criteria
for the purpose of this subgroup analysis were reconstructions using a
mesh and/or flap, other pelvic malignancies, pT4 stage, and adjacent
organ resection.We also performed a planned subgroup analysis only
in patients who received preoperative radiotherapy.
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RESULTS
Literature Search and Selection
The results of the literature search are displayed in Figure 1.
After deduplication, the combined search yielded 1081 articles, of
which 26 were identified as potentially eligible. After contacting the
authors, individual patient data were provided in six4–6,22–24 and
aggregate data in four.25–28 An additional of 4 studies with full text of
the original paper only were included.9,10,29,30 Eleven studies without
separate data for OP,31–41 and 1 study that eventually appeared to
have included only 1 patient with OP42 were excluded.
Study Characteristics
General study descriptions are demonstrated in Table 1.
Eleven studies had a control group (ie, 10 cases of non-
OP).2,4,6,9,10,22–24,26,28,30 The quality of the included studies
was moderate to good (range 5–9; Supplementary Table 2; Supple-
mental Digital Content 2, http://links.lww.com/SLA/B624). The 14
FIGURE 1. PRISMA flow diagram depicting the search strategy and study selection process. PRISMA indicates preferred reporting
items for systematic reviews and meta-analysis.
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included studies covered a total of 1894 patients, of whom 839
underwent OP.
Pooled baseline characteristics of the 2 groups are demon-
strated in Table 2. The indication for APR was predominantly rectal
cancer (87.2%). The number of patients receiving neo-adjuvant
radiotherapy was 82.5% in the OP group and 74.4% in the non-
OP group. Similar proportions of adjacent organ resection were
performed (21.4% vs 18.2%) with slightly less additional reconstruc-
tive procedures in the OP group (17.8% vs 27.5%). Median operative
time was median 19 minutes longer for APR with OP, but not
TABLE 2. Pooled Baseline Characteristics of Study Population With (OP) and Without Omentoplasty (Non-OP)
All Patients (n ¼ 1894)
Nonlocally Advanced Rectal Cancer and
Primary Perineal Closure (n ¼ 758)
OP (n ¼ 839) Non-OP (n ¼ 1055) OP (n ¼ 281) Non-OP (n ¼ 477)
Age
Years (median [IQR]) 64.3 [61.9–66.6] 64.0 [61.7–66.2] 64.9 [62.5–67.3] 66.2 [64.2–68.1]
Sex
Male 438 (52%) 659 (62%) 204 (73%) 321 (67%)
Female 280 (33%) 355 (34%) 77 (27%) 156 (33%)
NR 121 (14%) 178 (17%) 0 (0%) 0 (0%)
Disease
Rectal cancer 693 (83%) 959 (91%) 281 (100%) 477 (100%)
Anal cancer 99 (12%) 52 (5%) 0 (0%) 0 (0%)
Other malignant disease 18 (2%) 3 (0%) 0 (0%) 0 (0%)
NR 29 (3%) 66 (6%) 0 (0%) 0 (0%)
Neoadjuvant therapy
None 104 (12%) 174 (16%) 18 (6%) 50 (10%)
Short course RTx (25 Gy) 93 (11%) 114 (11%) 86 (31%) 168 (35%)
Long course RTx (40–60 Gy) 78 (9%) 34 (3%) 15 (5%) 22 (5%)
CRTx 319 (38%) 360 (34%) 147 (52%) 220 (46%)
NR 245 (29%) 373 (35%) 0 (0%) 0 (0%)
Type of resection
APR 594 (71%) 793 (75%) 281 (100%) 477 (100%)
APR with MVR 154 (18%) 175 (17%) 0 (0%) 0 (0%)
Total pelvic exenteration 8 (1%) 1 (0%) 0 (0%) 0 (0%)
NR 83 (10%) 86 (8%) 0 (0%) 0 (0%)
Perineal closure
Primary suturing 690 (82%) 765 (73%) 281 (100%) 477 (100%)
Muscle flap reconstruction 42 (5%) 127 (12%) 0 (0%) 0 (0%)
Mesh closure 107 (13%) 163 (15%) 0 (0%) 0 (0%)
NR 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Follow-up time
Mo [Median (IQR)] 36.6 [24.6–48.6] 36.6 [22.7–50.5] 37.9 [19.3–56.5] 36.8 [19.6–53.8]
Percentages might not add up due to rounding.
CRTx indicates chemoradiotherapy; IQR, interquartile range; MVR, multivisceral resection; NR, not reported; RTx, radiotherapy.
TABLE 1. Study Descriptions of the Included Studies
Study
(Author) Year Country Design Quality Disease
Patients
(n ¼ 1894)
OP
(n ¼ 839)
Non-OP
(n ¼ 1055)
De Broux et al 2005 France Retrospective cohort study 5 Rectal cancer 92 92 0
Lefevre et al 2009 France Retrospective cohort study 7 Anal cancer 95 52 43
Hultman et al 2010 USA Retrospective cohort study 5 Rectal cancer and anal cancer 70 29 41
Kirzin et al 2010 France Retrospective cohort study 6 Rectal cancer 109 19 90
Oida et al 2012 Japan Retrospective cohort study 8 Rectal cancer 45 20 25
Dumont et al 2012 France Retrospective cohort study 6 Rectal cancer, anal cancer, and other 132 101 31
Hawkins et al 2014 USA Retrospective cohort study 8 Rectal cancer 251 109 142
Musters et al 2014 Netherlands Retrospective cohort study 9 Rectal cancer 128 50 78
Hardt et al 2016 Germany Retrospective cohort study 6 Anal cancer 17 16 1
Hellinga et al 2016 Netherlands Retrospective cohort study 5 Rectal cancer, anal cancer, and other 24 20 4
Jones et al 2017 United Kingdom Prospective cohort study 6 Rectal cancer and anal cancer 266 42 224
Musters et al 2017 Netherlands Prospective cohort studya 9 Rectal cancer 99 61 38
Blok et al 2018 Netherlands Retrospective cross-sectional
cohort study
9 Rectal cancer 477 172 305
Baloch et al 2018 Sweden Retrospective cohort study 8 Rectal cancer, anal cancer, and other 89 56 33
Newcastle-Ottawa Quality Assessment Scale; a, randomized controlled trial of biomesh versus primary perineal closure, in which omentoplasty was at the discretion of the
operating surgeon.
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significantly different from the non-OP group. Median follow-up
duration of the included studies ranged from 12 to 62 months (overall
weighted mean 36.6 mo). Supplementary Table 3 (Supplemental
Digital Content 3, http://links.lww.com/SLA/B624) shows the base-
line characteristics and operative details for each of the
included studies.
Study Endpoints
Supplementary Table 4 (Supplemental Digital Content 4,
http://links.lww.com/SLA/B624) shows the outcomes for each of
the included studies. The main findings of the study are summarized
in Table 3. Visual inspection of the funnel plots for the main
outcomes of interest did not suggest presence of significant publica-
tion bias (Supplementary Figure 1; Supplemental Digital Content 5,
http://links.lww.com/SLA/B624).
Presacral Abscess
Twelve studies recorded the incidence of presacral abscess
formation.4–6,10,22–29 The overall weighted mean proportion of
presacral abscess formation following OP was 8.7% (95% CI
6.1%–12.3%). Considering 9 comparative studies,4–6,10,22–24,26,28
presacral abscesses similarly occurred after OP and non-OP (RR
1.11; 95% CI 0.79–1.56; I2 ¼ 0%) (Fig. 2A). The risk of presacral
abscess was also similar in the predefined subgroup of APR with
primary perineal closure for nonlocally advanced rectal cancer (RR
1.06; 95% CI 0.68–1.64; I2¼ 0%) (Fig. 2B).4–6,23,24 Similarly, there
was no reduced risk of developing presacral abscesses after OP when
only analyzing the patients who have been treated with preoperative
radiotherapy (RR 0.94; 95% CI 0.61–1.45; I2 ¼ 0%).2,4,6,23,24
Perineal Wound Healing
Eight studies recorded the primary perineal wound heal-
ing.2,4,24–29 The overall weighted mean cumulative proportion of
complicated wound healing at 30 days following OP was 50.6%
(95% CI 35.5%–65.6%). In 5 comparative studies,2,4,24,26,28 the rate
of complicated wound healing within 30 days was not significantly
different after OP and non-OP (RR 1.30; 95% CI 0.92–1.82; I2 ¼
74%). In subgroup analysis of APR with primary perineal closure for
nonlocally advanced disease, the association of OP with 30-day
wound complications remained nonsignificant (RR 1.28; 95% CI
0.64–2.56; I2 ¼ 73%).2,4,24 There was no reduced risk of pelviper-
ineal morbidity within 1 year (RR 1.18; 95% CI 0.80–1.74; I2 ¼
80%)2,4,22,24,28 or within the total study period (RR 1.09; 95% CI
0.83–1.44; I2 ¼ 69%)2,4,9,10,22–24,28,30 for patients submitted to OP.
Time to complete healing was not uniformly reported with
regard to patient population (eg, all patients or only those with
dehiscence) and measuring unit (eg, days or weeks) (Supplementary
Table 4; Supplemental Digital Content 4, http://links.lww.com/SLA/
B624). The included studies demonstrated no significant difference
in time to achieve perineal wound healing in terms of mean number
of days (mean differences 24 d in favor of non-OP; 95% CI minus 11
to 59; I2 ¼ 80%),23,24,26,30 or the proportion of patients in whom the
perineal wound was healed within 3 months (RR 1.01; 95% CI 0.92–
1.10; I2 ¼ 0%).4,6,22,23
Specific Pelviperineal Complications
The pooled proportions of specific pelviperineal complica-
tions following OP are demonstrated in Supplementary Figure 2
(Supplemental Digital Content 6, http://links.lww.com/SLA/B624).
After OP, the overall weighted mean incidence of wound dehiscence
was 32.2% (95% CI 22.6%–43.5%),2,4,6,9,22–24,26–29 which was
20.0% (95% CI 11.4%–32.9%) for superficial perineal infec-
tion,2,4,9,10,23–29 4.1% (95% CI 1.6%–10.5%) for hemorrhage,2,9,24
and 8.0% (95% CI 5.1%–12.4%) for perineal sinus.2,4,6,9,22–24,28,29
There were no statistically significant differences among patients
with and without OP in terms of perineal wound dehiscence (RR
1.21; 95% CI 0.96–1.53; I2 ¼ 54%),2,4,6,9,22–24,26,28 superficial
perineal infection (RR 0.85; 95% CI 0.45–1.62; I2 ¼
78%),2,4,9,10,23,24,26,28 pelviperineal hemorrhage (RR 1.39; 95% CI
0.29–6.58; I2 ¼ 25%),2,9,24 or chronic perineal sinus (RR 1.08; 95%
CI 0.53–2.20; I2 ¼ 56%)2,4,6,9,22–24,28 (Supplementary Figure 3,
Supplemental Digital Content 7, http://links.lww.com/SLA/B624).
Ileus
Twelve studies recorded the incidence of ileus.2,4,6,9,10,23–29 In
the OP group, the overall weighted mean proportion of ileus was
7.8% (95% CI 4.2%–14.2%),2,4,9,10,23–26,29 and 3.8% (95% CI
2.3%–6.2%) required reoperation for ileus.2,4,6,25,27–29 Considering
TABLE 3. GRADE Summary of Findings Table of the Effects of Omentoplasty for Filling of the Pelvic Cavity Following Abdom-
inoperineal Resection
Patient population: Patients who underwent abdominoperineal resection for malignant disease
Intervention: Omentoplasty
Comparison: No omentoplasty
Outcomes
Relative
Effect 95% CI I2
No. of Participants
(Studies)
Quality of the
Evidence (GRADE)
Complicated wound healing < 30 d RR 1.30 0.92–1.82 74% 853 (5) High
Any complicated wound healing < follow-up RR 1.09 0.83–1.44 69% 1033 (9) High
Superficial perineal infection RR 0.85 0.45–1.62 78% 1100 (8) Moderate
Presacral abscess RR 1.11 0.79–1.56 0% 1596 (9) High
Perineal dehiscence RR 1.21 0.96–1.53 54% 1621 (9) Moderate
Perineal hemorrhage RR 1.39 0.29–6.58 25% 307 (3) Low
Persistent perineal sinus RR 1.08 0.53–2.20 56% 1370 (8) Moderate
Perineal hernia RR 1.85 1.26–2.72 0% 1584 (9) Moderate
Ileus RR 0.90 0.62–1.31 0% 789 (6) Moderate
Reoperation for pelviperineal complication RR 1.06 0.80–1.42 0% 1401 (9) High
GRADE Working Group grades of evidence.
High quality: further research is very unlikely to change our confidence in the estimate effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
CI indicates confidence interval; I
2
, test for heterogeneity; RR, risk ratio.
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8 comparative studies, overall incidence of ileus was not significantly
different with or without OP (RR 0.90; 95% CI 0.62–1.31; I2 ¼
0%),2,4,9,23,24,26 nor the proportion of ileus requiring reoperation (RR
1.19; 95% CI 0.58–2.44; I2 ¼ 0%).2,4,6,28
Perineal Hernia
Twelve studies evaluated the incidence of perineal her-
nia.2,4,6,9,22,24–30 The overall weighted mean proportion of perineal
hernia was 8.9% (95% CI 5.7–13.7%) in those undergoing OP. Nine
comparative studies recorded the incidence of perineal her-
nia.2,4,6,9,22,24,26,28,30 The risk of perineal hernia was significantly
increased in those submitted to OP compared with non-OP (RR 1.85;
95% CI 1.26–2.72; I2 ¼ 0%) (Fig. 3A). This association remained
similar in those who underwent APR with primary perineal closure
for nonlocally advanced disease (RR 1.83; 95% CI 1.17–2.87; I2 ¼
0%) (Fig. 3B).2,4,6,24
Omental Flap Complications
Among 8 studies, the weighted mean proportion of OP-related
complications was 4.6% (95% CI 2.5%–8.6%).2,4,9,10,25,27–29 Spe-
cific complications of the OP included signs of inflammation of the
omentum (n ¼ 1), partial omental necrosis (n ¼ 1), total omental
infarction (n ¼ 1), perineal dehiscence with omental protrusion due
to necrosis of the OP (n ¼ 4), hemorrhagic shock due to bleeding of
the gastro-epiploic artery (n ¼ 1), and internal herniation of small
bowel underneath the OP (n ¼ 1).
Surgical Reintervention
In 12 studies on OP, the overall weighted mean proportion of
pelviperineal complications necessitating surgery (including hernia
repair) was 12.6% (95% CI 9.0%–17.4%),2,4,6,9,10,22,23,25,27–30 with-
out significant difference between OP and non-OP (RR 1.06; 95% CI
0.80–1.42; I2 ¼ 0%).2,4,6,9,10,22,23,28,30 Hernia repair tended to be
more frequent in the OP group (RR 1.71; 95% CI 0.87–3.35; I2 ¼
0%).2,4,6,28 Problems related to the OP itself were reason for reoper-
ation in 3.8% (95% CI 1.9%–7.6%).2,4,9,25,27,28
DISCUSSION
In the current literature review with mainly source patient
data, we found no evidence to suggest that OP reduces pelviperineal
abscess formation, nor that OP enhances perineal wound healing
FIGURE 2. Meta-analyses comparing presacral abscess formation between patients with and without omentoplasty in (A) all
patients who underwent APR for malignancy, and (B) patients who underwent APR with primary perineal closure for nonlocally
advanced rectal cancer.
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considering any other endpoint, or that OP reduces the risk of small
bowel obstruction. Similarly, no beneficial effect of OP was found in
planned subgroup analysis of patients who underwent APR with
primary perineal closure for nonlocally advanced cancer, thereby
likely reducing the risk of allocation bias. Furthermore, OP itself is
associated with a small risk of complications and appears to be
associated with perineal herniation.
The absence of any beneficial effects of OP as found in the
present meta-analysis is in contrast to literature on autologous tissue
flaps for perineal wound closure following APR.11,43 In particular,
the use of a VRAM flap is well established.8,30,44 However, studies
directly comparing muscle flaps and OP are scarce. A retrospective
single institutional study by Lefevre et al30—which was included in
the present review—found that VRAM flap closure was associated
with less perineal morbidity, reduced healing time, and no perineal
herniation (0% vs 15.4%; P ¼ 0.0072) if compared with primary
layered closure with OP. There are several potential explanations as
to why OP is not associated with such favorable outcomes. Probably,
the omentum is more likely to leave residual dead space, especially
with thin patients. Furthermore, OP might have less robust blood
supply after full mobilization, and compromised perfusion of an OP
is sometimes difficult to recognize intraoperatively. An OP with
partial necrosis of the most distal parts, which are subsequently
placed in the perineal wound, will likely counterbalance any benefi-
cial effect in other patients. But in our opinion, the most crucial
difference between OP and VRAM flap reconstruction is the filling
of anal dead space. The muscle, fascia, subcutaneous fat, and skin of
a VRAM flap are perfectly suited for the reconstruction of the pelvic
floor and perineal defect, while an OP only consists of loose fatty
tissue that does not provide any strength. OP mainly fills the
presacral space, but the excised anal canal and sphincter complex
seems to be the critical wound bed. The small bowel can fill the
presacral space in the absence of an OP, as will occur after VRAM
flap reconstruction.
Incidence of perineal hernia was around 10%, and is likely to
even be an underestimation of the true incidence because of the
retrospective design of most included studies. In meta-analysis,
perineal hernia correlated significantly with the use of OP. This
finding has recently been demonstrated in a nationwide study,6 but
was felt to be counterintuitive by some surgeons, and probably best
explained by wider resections in the OP group. But this phenomenon
may also be explained by the properties of an OP. As previously
FIGURE 3. Meta-analyses comparing perineal hernia development between patients with and without omentoplasty in (A) all
patients who underwent APR for malignancy, and (B) patients who underwent APR with primary perineal closure for nonlocally
advanced rectal cancer.
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mentioned, the fatty and nonfibrous omentum is not providing any
strength to the neo-pelvic floor, and even puts continuous pressure on
the perineal skin in a standing position. It is understandable that, in
case of a bulky OP with a long vascular pedicle, such redundant bulk
of fat is more likely to descend below the level of the pelvic floor than
a few loops of small bowel that are often restricted by a certain
mesenteric length. The omental fat is certainly more likely to result in
perineal bulging than VRAM flap closure where muscle and fascia is
added to the neo-pelvic floor.30
Two systematic reviews on the value of OP after APR have
been published previously, both in contradiction with the current
meta-analysis.45,46 Compared with the review of Nilsson 46 only 1
study29 is overlapping, and only three9,10,29 out of 14 studies are
overlapping with the review by Killeen et al.45 Most of the older
studies that were included in both previous reviews concern a small
sample size and diversity regarding patient population and surgical
methods, with only few comparative series. In addition, the rather
historical studies have restricted generalizability, especially consid-
ering the less frequent use of preoperative radiotherapy. Strengths of
the current review are restricted inclusion of publication since 2000,
more comparative studies, and the use of primary source patient data,
even if the original publication was not intended to study the effect of
OP. Furthermore, benign pathology such as IBD was excluded, in
contrast to the previous reviews. This resulted in more homogeneous
patient populations with higher internal and external validity than
previous systematic reviews published on the subject.45,46 These
methodological issues may explain the contradictory findings.
The main limitation of our study is the potential for a certain
degree of allocation bias. In the absence of randomized controlled
trials, it could be that surgeons selectively applied OP in those with a
larger empty space after resection, and therefore an a priori greater
risk of wound complications and hernia. To reduce potential con-
founding, a subgroup analysis was performed by excluding extended
resections and additional reconstructive procedures. Even then,
however, the potential for allocation bias cannot be excluded. A
second limitation is that the definition of outcome variables in the
source studies may be variable. In particular, the lack of a clear
definition for presacral abscess and perineal hernia (ie, symptomatic
perineal bulge or asymptomatic radiological finding) could poten-
tially have influenced our results. However, reporting of perineal
hernia was predominantly based on retrospective analysis of patient
records, most likely not including small and asymptomatic radiolog-
ical hernias. Also, total number of events was used for meta-analysis
of perineal hernia, not properly taking into account the development
of perineal hernia over time and differences among studies regarding
duration of follow-up.
Based on the available literature, OP does not seem indicated
for decreasing perineal wound complications after APR for cancer,
nor does biological mesh closure.4 Tissue transfer seems to have the
greatest potential, but high-quality studies comparing muscle flap
closure to other methods of perineal wound closure are warranted.
Although VRAM flap closure has been effectively used in selective
populations,8 there remains the issue of donor and recipient site
morbidity.43,47 A smaller flap without donor site problems such as the
perineal turnover flap48 seems attractive. We are currently evaluating
the effectiveness of a modified gluteal turnover flap49 for routine use
after APR, and we consider larger fascio-cutaneous gluteal or VRAM
flaps only for the wider perineal defects with a high risk of sinus
formation.
CONCLUSIONS
In this systematic review and meta-analysis, that is reflecting
current surgical practice of patients who are submitted to APR for
malignant disease, we found no evidence to support the use of an OP
for reducing pelviperineal morbidity. Additionally, use of OP has an
added risk of OP associated complications, and seems to be associ-
ated with the long-term likelihood of developing perineal hernia.
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